Variable | N | cGVHD | Extensive cGVHD | ||||
---|---|---|---|---|---|---|---|
 |  | HR | 95% CI | P | HR | 95% CI | P |
Age for recipients, years | Â | Â | Â | Â | Â | Â | Â |
<40 | 286 | 1.00 | Â | Â | 1.00 | Â | Â |
≥40 | 180 | 1.34 | 1.06-1.70 | 0.016 | 1.54 | 1.12-2.11 | 0.007 |
Age for donor, years | Â | Â | Â | Â | Â | Â | Â |
<40 | 288 | 1.00 | Â | Â | 1.00 | Â | Â |
≥40 | 178 | 1.10 | 0.848-1.43 | 0.473 | 1.362 | 0.971-1.912 | 0.074 |
Age for donor and recipients, years | Â | Â | Â | Â | Â | Â | Â |
recipients < 40 and donor < 40 | 243 | 1.00 |  |  | 1.00 |  |  |
recipients < 40 and donor ≥ 40 | 52 | 0.72 | 0.46-1.15 | 0.174 | 0.90 | 0.49-1.64 | 0.729 |
recipients ≥ 40 and donor < 40 | 47 | 1.24 | 0.82-1.88 | 0.314 | 1.46 | 0.84-2.53 | 0.179 |
recipients ≥ 40 and donor ≥ 40 | 124 | 1.38 | 1.03-1.85 | 0.034 | 1.76 | 1.20-2.59 | 0.004 |
Donor-recipient gender | Â | Â | Â | Â | Â | Â | Â |
Other | 336 | 1.00 | Â | Â | 1.00 | Â | Â |
Female → Male | 130 | 1.48 | 1.15-1.90 | 0.002 | 1.92 | 1.39-2.65 | 0.000 |
Stem cell source | Â | Â | Â | Â | Â | Â | Â |
BM + PB | 241 | 1.00 |  |  | 1.00 |  |  |
PB | 225 | 0.51 | 0.40-0.65 | 0.000 | 0.30 | 0.21-0.43 | 0.000 |
Leukemia type | Â | Â | Â | Â | Â | Â | Â |
AL | 287 | 1.00 | Â | Â | 1.00 | Â | Â |
CML | 145 | 1.04 | 0.80-1.34 | 0.778 | 0.94 | 0.66-1.35 | 0.747 |
Conditioning regimen | Â | Â | Â | Â | Â | Â | Â |
BuCy | 326 | 1.00 | Â | Â | 1.00 | Â | Â |
TBICy | 23 | 0.66 | 0.34-1.29 | 0.226 | 0.56 | 0.21-1.54 | 0.264 |
BuFlu | 116 | 1.49 | 1.15-1.94 | 0.003 | 1.96 | 1.41-2.73 | 0.000 |
Donor-recipient blood type | Â | Â | Â | Â | Â | Â | Â |
Match | 273 | 1.00 | Â | Â | 1.00 | Â | Â |
Mis-match | 193 | 1.14 | 0.89-1.45 | 0.301 | 1.18 | 0.85-1.60 | 0.317 |
Disease Stage | Â | Â | Â | Â | Â | Â | Â |
Non-advanced | 415 | 1.00 | Â | Â | 1.00 | Â | Â |
Advanced | 51 | 1.19 | 0.80-1.78 | 0.389 | 0.96 | 0.54-1.70 | 0.890 |
aGVHD | Â | Â | Â | Â | Â | Â | Â |
No | 332 | 1.00 | Â | Â | 1.00 | Â | Â |
Yes | 134 | 1.82 | 1.42-2.34 | 0.000 | 2.14 | 1.55-2.96 | 0.000 |